Skip to main content
SpringerLink
Log in

New boxed warning for Tygacil

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. see Reactions 1318 p6; 801140769

Reference

  • FDA. FDA Drug Safety Communication: FDA warns of increased risk of death with IV antibacterial Tygacil (tigecycline) and approves new Boxed Warning. Internet Document : 27 Sep 2013. Available from: URL: http://www.fda.gov

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

New boxed warning for Tygacil. Reactions Weekly 1472, 3 (2013). https://doi.org/10.1007/s40278-013-6227-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-013-6227-3

Search

Navigation